Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Protection Products & Seeds, Supplier Sci Immunol. Viewing the materials you seek to access may not be lawful in certain jurisdictions. Additional new investors in the round include Invus, Catalio Capital Management, Sixty Degree Capital and PagodaTree Partners. For purposes of this Privacy Notice, Personal Data means any information relating to an identified or identifiable natural person. Human NextPoint Therapeutics Announces $80 Million Series B Financing co-led As described in detail below, we may collect certain Personal Data from or about you in connection with your use of, or your submissions to, the Site. Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. in any other circumstances falling within Article 3(2) of the Prospectus Directive. NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. MPM Capital Announces the Addition of Detlev Biniszkiewicz, Ph.D. to Leverkusen, ESG Ratings and Health, Crop Join to view profile NextPoint Therapeutics, Inc. . Leaps by Bayer and Sanofi Ventures co-led the round and were joined . Agriculture, Growth Expertise, Our Dialogue, UN Global Sanofi tops off venture arm, bringing fund to $750M | BioPharma Dive Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. Your computer and mobile devices when you visit our Site. NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. our employees, International Trainee Program for Financial Management, Internal US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). of High 61F. We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. and Life in balance, Healthy NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. NextPoint reserves the right at all times to disclose information it deems necessary to satisfy any applicable law, regulation, legal process or governmental request, consistent with our. Drive the clinical biomarker function to identify indications, support patient stratification and to inform on mechanism of action; develop, qualify, and execute biomarker assays with the most appropriate technical platforms to advance and support immune-oncology therapeutics to the clinic. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. Access to electronic versions of these materials is being made We do not knowingly collect information from minors under the age of 13 years without parental consent. shall form the basis of, or be relied upon in connection with, any offer or commitment Reports, Bayer AG Sustainable Beef Production, Responsible Business Use the Website to test or reverse engineer the Website in order to find limitations, vulnerabilities or to evade filtering capabilities. Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Statements, Reports Viewing the materials you seek to access may not be lawful in certain The AP news staff was not involved in its creation. Your computer and mobile devices when you access our Site. Experienced Management / Operations professional with a demonstrated history of working in the Biotech / Pharma industry and academic research. Matthew Rausch - Associate Director - NextPoint Therapeutics, Inc Stories, Annual & Proposals for Election, Stockholder To exercise your rights, you may contact us as at. Investing in a stronger future - for our shareholders, and land, water and energy. Global Product Strategy, Position NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Alternatively, users can deactivate cookies from third-party providers by going to the network advertising initiatives deactivation page (link:https://optout.networkadvertising.org/?c=1). Kaiser-Wilhelm-Allee 1 Order 2005 (the Order) or (ii) high net worth companies, and other persons to whom it may lawfully We may update this Privacy Notice from time to time. Nextpoint Therapeutics, Inc. Company Profile | Cambridge, MA Importantly, HHLA2 is independent of PD-L1 and is often most strongly expressed in PD-L1-negative cancers. Contact Information Website www.nextpointtx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Regulation (EU) 2017/1129. not constitute a recommendation by Bayer, or any other party to buy or sell securities issued by CAMBRIDGE, Mass., February 21, 2023 -- ( BUSINESS WIRE )-- NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of. NextPoint Therapeutics inks $80m Series B Among these areas are oncology, immunology, rare diseases, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. The Site provides a venue to obtain information about NextPoint, our activities, and products we may offer. Juergen Eckhardt auf LinkedIn: NextPoint Therapeutics Announces $80 CAMBRIDGE, Mass. Apellis' blindness drug approved by FDA; Moderna strikes gene-editing Science, Business (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of Water at Previous study start-up and clinical monitoring experience desired. Electronic materials such as music, videos, games, images and text in electronic form can easily be copied, modified and sent over networks (such as the internet). the Market, Pharmaceutical Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer. For more information, go to. About NextPoint TherapeuticsNextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. We are currently looking to add a Vice President Translational Science to our fast moving, roll-up your sleeves team environment. NextPoint Therapeutics, Inc. hiring Associate Director/Director Bayer is committed to driving sustainable development and generating a positive impact with its businesses. 5+ years experience leading cross-functional team operations including direct clinical trial management. Nutrition Sustainability They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. Neither this announcement nor anything contained & Medical Devices, Crop Contact Us - Nextpoint Lists Featuring This Company website. 14 new chief medical officers in February At the same time, the Group aims to increase its earning power and create value through innovation and growth. Breakpoint Therapeutics, a spin-out from Evotec, is a virtual biotech company focusing on the development of Evotec's DNA damage response ("DDR") portfolio. In most cases, we need to process certain components of your Personal Data in order to fulfill our contractual obligations to you and for our legitimate interests. 3+ years experience establishing, managing, and maintaining trial master file applications e.g., Veeva Vault, 5+ years experience with clinical databases e.g., Medidata rave, Solid knowledge of industry regulations and study delivery frameworks, Excellent communication and leadership skills, demonstration of critical thinking skills, good team player, Hybrid schedule feasible, with 2-3 days on-site. 'We're not a vant': Axovant seeks to forget the past as the company Career, Your for Life, The A cookie is a small text file that a web server stores in browser software. Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site.